- Home
- CYCC vs SXTP Comparison
CYCC vs SXTP Comparison
Compare CYCC & SXTP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYCC
- SXTP
- Stock Information
- Founded
- CYCC 1992
- SXTP 2010
- Country
- CYCC United States
- SXTP United States
- Employees
- CYCC N/A
- SXTP N/A
- Industry
- CYCC Biotechnology: Pharmaceutical Preparations
- SXTP Biotechnology: Pharmaceutical Preparations
- Sector
- CYCC Health Care
- SXTP Health Care
- Exchange
- CYCC Nasdaq
- SXTP Nasdaq
- Market Cap
- CYCC 1.8M
- SXTP 1.6M
- IPO Year
- CYCC N/A
- SXTP 2023
- Fundamental
- Price
- CYCC $0.37
- SXTP $0.90
- Analyst Decision
- CYCC Buy
- SXTP Hold
- Analyst Count
- CYCC 2
- SXTP 1
- Target Price
- CYCC $11.00
- SXTP N/A
- AVG Volume (30 Days)
- CYCC 3.7M
- SXTP 87.9K
- Earning Date
- CYCC 11-12-2024
- SXTP 11-26-2024
- Dividend Yield
- CYCC N/A
- SXTP N/A
- EPS Growth
- CYCC N/A
- SXTP N/A
- EPS
- CYCC N/A
- SXTP N/A
- Revenue
- CYCC $74,000.00
- SXTP $462,612.00
- Revenue This Year
- CYCC N/A
- SXTP $267.05
- Revenue Next Year
- CYCC $16.28
- SXTP $181.82
- P/E Ratio
- CYCC N/A
- SXTP N/A
- Revenue Growth
- CYCC N/A
- SXTP 12.07
- 52 Week Low
- CYCC $0.35
- SXTP $0.70
- 52 Week High
- CYCC $6.00
- SXTP $18.36
- Technical
- Relative Strength Index (RSI)
- CYCC 29.98
- SXTP 47.11
- Support Level
- CYCC $0.35
- SXTP $0.87
- Resistance Level
- CYCC $0.52
- SXTP $1.14
- Average True Range (ATR)
- CYCC 0.07
- SXTP 0.12
- MACD
- CYCC -0.01
- SXTP 0.02
- Stochastic Oscillator
- CYCC 3.94
- SXTP 53.88
About CYCC Cyclacel Pharmaceuticals Inc.
Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors, and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib, Sapacitabine, and plogosertib.
About SXTP 60 Degrees Pharmaceuticals Inc.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.